CN102068641A - Chinese medicinal capsules for treating gynecological diseases - Google Patents
Chinese medicinal capsules for treating gynecological diseases Download PDFInfo
- Publication number
- CN102068641A CN102068641A CN 201010505055 CN201010505055A CN102068641A CN 102068641 A CN102068641 A CN 102068641A CN 201010505055 CN201010505055 CN 201010505055 CN 201010505055 A CN201010505055 A CN 201010505055A CN 102068641 A CN102068641 A CN 102068641A
- Authority
- CN
- China
- Prior art keywords
- grams
- blood
- rhizoma
- radix
- pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 25
- 201000010099 disease Diseases 0.000 title abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 239000009636 Huang Qi Substances 0.000 claims description 9
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 9
- 241000237903 Hirudo Species 0.000 claims description 8
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 6
- 239000003814 drug Substances 0.000 abstract description 38
- 208000002193 Pain Diseases 0.000 abstract description 37
- 208000005171 Dysmenorrhea Diseases 0.000 abstract description 24
- 230000000694 effects Effects 0.000 abstract description 24
- 206010013935 Dysmenorrhoea Diseases 0.000 abstract description 23
- 210000001015 abdomen Anatomy 0.000 abstract description 21
- 208000019255 Menstrual disease Diseases 0.000 abstract description 16
- 206010046798 Uterine leiomyoma Diseases 0.000 abstract description 10
- 208000025661 ovarian cyst Diseases 0.000 abstract description 7
- 206010034238 Pelvic adhesions Diseases 0.000 abstract description 6
- 241000748223 Alisma Species 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 241000736199 Paeonia Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 240000005001 Paeonia suffruticosa Species 0.000 abstract 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 241000329195 Sparganium erectum Species 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 208000000509 infertility Diseases 0.000 abstract 1
- 230000036512 infertility Effects 0.000 abstract 1
- 231100000535 infertility Toxicity 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 230000002969 morbid Effects 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 70
- 239000008280 blood Substances 0.000 description 70
- 210000004185 liver Anatomy 0.000 description 24
- 210000000952 spleen Anatomy 0.000 description 22
- 230000001737 promoting effect Effects 0.000 description 19
- 230000017531 blood circulation Effects 0.000 description 17
- 201000000736 Amenorrhea Diseases 0.000 description 16
- 206010001928 Amenorrhoea Diseases 0.000 description 16
- 231100000540 amenorrhea Toxicity 0.000 description 16
- 229940079593 drug Drugs 0.000 description 15
- 235000009508 confectionery Nutrition 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 9
- 206010000087 Abdominal pain upper Diseases 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 8
- 239000000470 constituent Substances 0.000 description 8
- 230000006378 damage Effects 0.000 description 8
- 208000035475 disorder Diseases 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 7
- 208000021267 infertility disease Diseases 0.000 description 7
- 230000000144 pharmacologic effect Effects 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 208000006820 Arthralgia Diseases 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 201000005630 leukorrhea Diseases 0.000 description 6
- 230000001603 reducing effect Effects 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 210000004291 uterus Anatomy 0.000 description 6
- 206010046901 vaginal discharge Diseases 0.000 description 6
- 239000000341 volatile oil Substances 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 5
- 208000007536 Thrombosis Diseases 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 5
- 230000001882 diuretic effect Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 210000003101 oviduct Anatomy 0.000 description 5
- 230000002269 spontaneous effect Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 239000002934 diuretic Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 230000010100 anticoagulation Effects 0.000 description 3
- 210000003679 cervix uteri Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- -1 n-butene acyl lactone Chemical class 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 206010061692 Benign muscle neoplasm Diseases 0.000 description 2
- 208000002881 Colic Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 201000004458 Myoma Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- ZPIKVDODKLJKIN-NSHDSACASA-N Senkyunolide Chemical compound C1CC=CC2=C1[C@H](CCCC)OC2=O ZPIKVDODKLJKIN-NSHDSACASA-N 0.000 description 2
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 description 2
- 108090000190 Thrombin Proteins 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- ZZAJQOPSWWVMBI-UHFFFAOYSA-N calycosin Chemical compound C1=C(O)C(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZZAJQOPSWWVMBI-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 201000003511 ectopic pregnancy Diseases 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000003119 painkilling effect Effects 0.000 description 2
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229960004072 thrombin Drugs 0.000 description 2
- 230000002537 thrombolytic effect Effects 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- PAFLSMZLRSPALU-MRVPVSSYSA-N (2R)-3-(3,4-dihydroxyphenyl)lactic acid Chemical compound OC(=O)[C@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-MRVPVSSYSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- IQVQXVFMNOFTMU-FLIBITNWSA-N (Z)-ligustilide Chemical compound C1CC=CC2=C1C(=C/CCC)/OC2=O IQVQXVFMNOFTMU-FLIBITNWSA-N 0.000 description 1
- WECGLUPZRHILCT-GSNKCQISSA-N 1-linoleoyl-sn-glycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@@H](O)CO WECGLUPZRHILCT-GSNKCQISSA-N 0.000 description 1
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical group OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000084 Abdominal pain lower Diseases 0.000 description 1
- ATWHGWYKSFRYBN-UHFFFAOYSA-N Amygdaloside Natural products O1C(=O)C2(C)CCCC(C3CC4)(C)C2C1OCC3(C1)CC4C1(O)COC1OC(CO)C(O)C(O)C1O ATWHGWYKSFRYBN-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- LAWPHHZXTUPSDG-UHFFFAOYSA-N Astragaloside I Natural products CC(=O)OC1C(O)COC(OC2CCC34CC35CCC6(C)C(C)(CCC6(O)C7(C)CCC(O7)C(C)(C)O)C5CC(OC8OC(CO)C(O)C(O)C8O)C4C2(C)C)C1OC(=O)C LAWPHHZXTUPSDG-UHFFFAOYSA-N 0.000 description 1
- KXHCYYSIAXMSPA-UHFFFAOYSA-N Astragaloside-I Chemical compound CC(=O)OC1C(OC(=O)C)C(O)COC1OC1C(C)(C)C2C(OC3C(C(O)C(O)C(CO)O3)O)CC3C4(C)CC(O)C(C5(C)OC(CC5)C(C)(C)O)C4(C)CCC43CC42CC1 KXHCYYSIAXMSPA-UHFFFAOYSA-N 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- PAFLSMZLRSPALU-QMMMGPOBSA-N Danshensu Natural products OC(=O)[C@@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-QMMMGPOBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 201000009273 Endometriosis Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000124449 Paeonia obovata Species 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- PAFLSMZLRSPALU-UHFFFAOYSA-N Salvianic acid A Natural products OC(=O)C(O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-UHFFFAOYSA-N 0.000 description 1
- 102000005686 Serum Globulins Human genes 0.000 description 1
- 108010045362 Serum Globulins Proteins 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- IQVQXVFMNOFTMU-DHZHZOJOSA-N Z-ligustilide Natural products C1CC=CC2=C1C(=C/CCC)\OC2=O IQVQXVFMNOFTMU-DHZHZOJOSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930188824 alisol Natural products 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000002300 anti-fibrosis Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 238000009811 bilateral tubal ligation Methods 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000157 blood function Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- HJCCJZGOBHFQSX-UHFFFAOYSA-N cyclosieversioside B Natural products CC(CCC(O)C(C)(C)OC1OC(CO)C(O)C(O)C1O)C2C(CC3(C)C4CC(O)C5C(C)(C)C(CCC56CC46CCC23C)OC7OCC(O)C(O)C7O)OC8OC(CO)C(O)C(O)C8O HJCCJZGOBHFQSX-UHFFFAOYSA-N 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 238000005220 pharmaceutical analysis Methods 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 229960003371 protocatechualdehyde Drugs 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930183325 senkyunolide Natural products 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses Chinese medicinal capsules for treating gynecological diseases. The Chinese medicinal capsules comprise the following raw material components by weight: 10 to 15 grams of Chinese angelica, 10 to 12 grams of white peony root, 9 to 10 grams of Szechuan lovage rhizome, 10 to 12 grams of cassia twig, 15 to 20 grams of salvia root, 12 to 20 grams of astragalus root, 10 to 12 grams of red peony root, 10 to 15 grams of tuckahoe, 10 to 12 grams of root-bark of tree peony, 10 to 12 grams of peach seed, 10 to 15 grams of large-headed atractylodes, 10 to 12 grams of alisma, 5 to 10 grams of common burreed rhizome, 10 to 15 grams of hawthorn fruit, 2 to 5 grams of leech, and 10 to 12 grams of nutgrass galingale rhizome. The Chinese medicament has good curative effect on the diseases such as gynecological lower abdomen pain, more morbid leucorrhea, lumbar and sacral sore, pelvic adhesion, hysteromyoma, ovarian cysts, menstrual disorder, dysmenorrhea, infertility and the like, has quick response and high curative ratio, and is convenient to take.
Description
Technical field
The present invention relates to a kind of Chinese medicine, particularly a kind of Chinese medicinal capsule for the treatment of gynaecopathia.
Background technology
Because women's physiological and pathological feature, gynaecopathia is many with the stagnation of QI, blood stasis, the damage of paathogenic factors such as phlegm-damp is dashed and is appointed, QI and blood, it is not normal to cause function, the vim and vigour imbalance, dash due to the wantonly two arteries and veins damage, how to stagnate, the stasis of blood, wet (liver-spleen disharmony), empty (prolonged illness must be empty) is feature, so gynaecopathia is many and liver, spleen, kidney three dirty relations are the tightst, and spleen is the main fortuneization of middle soil, be source of generating QI and blood, liver is general's official, and its property is firm, and main catharsis bar reaches, with soft be suitable, reach if liver is lost bar, dysfunction of the spleen in transportation causes incoordination between the liver and spleen, and the mechanism of qi retardance then can cause lower abdomen pain, distending pain in the chest and hypochondrium, profuse leukorrhea, lumbosacral aching pain, channels are hindered then sees fallopian tube adhesion or pelvic adhesion; Qi depression to blood stasis, phlegm resistance be hair growth promoting note of the ancient Chinese abdominal mass mass in the abdomen such as hysteromyoma then, ovarian cyst; The kidney being the origin of congenital constitution, main reproduction, " going out all kidneys " through water, menoxenia then appears in the imbalance between YIN and YANG of kidney, dysmenorrhea, infertile etc., so its symptom main clinical manifestation is: lower abdomen pain, profuse leukorrhea, lumbosacral aching pain, pelvic adhesion, hysteromyoma, ovarian cyst, menoxenia, dysmenorrhea, symptom such as infertile, Chinese patent medicine, the Western medicine for the treatment of this type of gynaecopathia at present are a lot, just cure the symptoms, not the disease, symptom is easily alleviated but easily outbreak repeatedly must not be eradicated.
Summary of the invention
The present invention is for avoiding above-mentioned existing in prior technology weak point, a kind of Chinese medicine for the treatment of gynaecopathia is provided, and this Chinese medicine cures mainly gynecological's lower abdomen pain, profuse leukorrhea, lumbosacral aching pain, pelvic adhesion, hysteromyoma, ovarian cyst, menoxenia, dysmenorrhea, this treatment by Chinese herbs gynaecopathia of disease such as infertile is effective, instant effect, the cure rate height.
Technical solution problem of the present invention adopts following technical scheme:
A kind of Chinese medicinal capsule for the treatment of gynaecopathia is characterized in that: the weight proportion of its raw material components is:
Radix Angelicae Sinensis 10-15g Radix Paeoniae Alba 10-12g Rhizoma Chuanxiong 9-10g Ramulus Cinnamomi 10-12g Radix Salviae Miltiorrhizae 15-20g Radix Astragali 12-20g Radix Paeoniae Rubra 10-12g Poria 10-15g Cortex Moutan 10-12g Semen Persicae 10-12g Rhizoma Atractylodis Macrocephalae 10-15g Rhizoma Alismatis 10-12g rhizoma sparganic 5-10g Fructus Crataegi 10-15g Hirudo 2-5g Rhizoma Cyperi 10-12g.
The Chinese medicinal capsule of described treatment gynaecopathia is characterized in that: the weight proportion of its raw material components is:
Radix Angelicae Sinensis 10g Radix Paeoniae Alba 10g Rhizoma Chuanxiong 10g Ramulus Cinnamomi 10g Radix Salviae Miltiorrhizae 15g Radix Astragali 15g Radix Paeoniae Rubra 10g Poria 15g Cortex Moutan 10g Semen Persicae 10g Rhizoma Atractylodis Macrocephalae 12g Rhizoma Alismatis 10g rhizoma sparganic 8g Fructus Crataegi 15g Hirudo 3g Rhizoma Cyperi 10g
Process for preparing medicine of the present invention is as follows:
1, all medicinal pulverizers are pulverized, and break into 80 order medicated powder;
2, medicated powder is adopted Chinese patent medicine vacuum drying sterilization cabinet sterilizing installation sterilize;
3, the medicated powder of sterilizing, make every zero capsule that contains 0.5g medicated powder, in the bottle of packing into, hermetic container is preserved the standby finished product that is.
Raw material in the compatibility of drugs of the present invention:
Radix Angelicae Sinensis: warm in nature, sweet, hot, enrich blood and invigorate blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.Be used for blood deficiency and yellow complexion, dizzy cardiopalmus, menoxenia, amenorrhea dysmenorrhea, asthenia cold abdominalgia, dryness of the intestine constipation, rheumatic arthralgia, injury from falling down, ulcer sores.Sweet in the mouth specially can be enriched blood, and its gas is light and hot, thus again can promoting the circulation of blood, and invigorating middle warmer has, in the row benefit is arranged, the gas medicine in the sincere blood.Chemical constituent: contain basic lactone, n-butene acyl lactone, ferulic acid, nicotinic acid, sucrose and several amino acids, and sesquiterpenoids etc.
The Radix Paeoniae Alba: bitter in the mouth, acid, cold nature; Return liver, spleen channel; The master goes into blood system, nourishing blood to suppress the hyperactive liver, and slow middle pain relieving, yin fluid astringing is received antiperspirant.Hold back and fall and microlitre looses; Has the yin fluid astringing of nourishing blood, suppressing the hyperactive liver, the effect of easing the affected liver to relieve pain; Cure mainly menoxenia, dysmenorrhea, metrorrhagia, leukorrhagia, spontaneous sweating, dizzy, headache, deficiency-heat, side of body rib epigastric pain, dysentery stomachache, rheumatic arthralgia, limb pain twin.
Radix Paeoniae Rubra: hardship, cold, go into Liver Channel, clearing away heat and cooling blood, stasis-dispelling and pain-killing.Be used for epidemic febrile disease, heat is gone into nutrient blood, heating, crimson tongue, body and is sent out macule, and bleeding due to blood-heat and amenorrhea, injury from falling down, stagnation of QI-bloods such as sore and toxic card.Chemical constituent, root contains paeoniflorin.The root of Paeonia obovata Maxim. contains volatile oil, fatty oil, resin, tannin, sugar, starch, phlegmatic temperament, protein etc.
The Radix Astragali: sweet, temperature.Return lung, spleen channel.Effect: invigorating QI to consolidate the body surface resistance, diuresis poison holding, evacuation of pus, expelling pus and promoting granulation.It is weak to be used for the deficiency of vital energy, anorexia and loose stool, and sinking of QI of middle-JIAO, the chronic diarrhea proctoptosis, the metrorrhagia of having blood in stool, the exterior deficiency spontaneous perspiration, deficiency of vital energy edema, carbuncle is difficult bursts, and burst for a long time and do not hold back, the blood deficiency dull yellowish colored skin, interior-heat is quenched one's thirst; Chronic nephritis proteinuria, diabetes.Chemical constituent contains flavones ingredient calycosin, 3-hydroxyl-9, and 10-dimethoxy Lignum pterocarpi indici alkane also contains astragaloside I, V, III.The invigorating middle warmer of processed with honey Radix Astragali QI invigorating.It is weak to be used for the deficiency of vital energy, anorexia and loose stool.Main particularly effect has four, promptly warm muscle and real space between skin and muscles; Benefit vigour and mend three warmers; The skin infection of expelling the toxic substance from the body with tonic YIN syndrome; The spontaneous perspiration of consolidating superficial resistance void.
Radix Salviae Miltiorrhizae: bitter in the mouth, cold nature, GUIXIN, Liver Channel.Promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind.Cure mainly menoxenia, the amenorrhea dysmenorrhea, lump in the abdomen, breast ventral spine pain, pyretic arthralgia pain, skin infection swells and ache, dysphoria and insomnia; Hepatosplenomegaly, angina pectoris.Be used for menoxenia due to the blood stasis, dysmenorrhea, amenorrhea, puerperal the stasis of blood stomachache that stagnates; Main chemical compositions contains TANSHINONES, protocatechualdehyde, protocatechuic acid, danshensu, vitamin E etc., and in addition its merit is good at: suppress or alleviate hepatocellular degeneration, necrosis and inflammatory reaction, promote liver cell regeneration, and anti-fibrosis effect is arranged; Antitumor action; The enhancing human body immunity function; Blood sugar lowering; Various bacteria such as tubercule bacillus there is inhibitory action.
Ramulus Cinnamomi: suffering, Gan Wen, GUIXIN, lung, urinary bladder channel.The effect relieving the exterior syndrome by diaphoresis, warming the meridian for promoting the flow of YANG QI.Main component is a volatile oil.Cure mainly affection of exogenous wind-cold, the aversion to cold of having a headache and fever, anemofrigid-damp arthralgia, the shoulder back of the body is dismembered pain, heart deficiency of spleen-YANG, the not all right retention of water-damp in the body of yang-energy and the phlegm retention syndrome that arrives, and the thoracic obstruction, chest pain or cardiopalmus, diseases such as irregularly intermittent and regularly intermittent pulse.Also can be used for stagnating amenorrhea, Tong Jing mass in the abdomen through the cold stasis of blood.
Poria: slightly sweet flavor, flat, go into the heart, lung, spleen channel.Has eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, the effect of mind tranquilizing and the heart calming.Can control dysuria, the edema distension, the phlegm retention cough with dyspnea, vomiting, malignant histocytosis is had loose bowels, seminal emission, stranguria with turbid discharge, palpitation with fear, forgetful disease such as grade.The diuretic of Poria reaches by strong activating the spleen pulmonary function, and is different with the Chinese medicine of other direct diuretic.Other effects: diuresis, antibiotic, antitumor.
Semen Persicae: bitter in the mouth, sweet is flat.GUIXIN, liver, large intestine channel.Function cures mainly: blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation, relieving cough and asthma.Be used for amenorrhea, dysmenorrhea,
WEIJIAMass in the abdomen, injury from falling down, dryness of the intestine constipation.Chemical constituent: contain amygdaloside, emulsin, volatile oil, fatty oil, mainly contain olein and a small amount of glyceryl linoleate in the oil.Pharmacological action: the Semen Persicae extracting solution is the cerebral blood flow increasing amount obviously, increases the blood flow of femoral artery, reduces vascular resistance, improves hemodynamic situation.Extract can improve the liver surface microcirculation of animal, and promotes bile secretion.Be summarized as: the effect of blood stasis dispelling blood, antiinflammatory action, anti-allergic effects.
Rhizoma Alismatis: sweet, light, cold, return kidney, urinary bladder channel.The effect diuretic, eliminating dampness by diuresis expels the heat-evil.Control dysuria, edema distension, vomiting, dysentery, phlegm retention, beriberi, gonorrhea, hematuria.Chemical constituent: alisol.Other effects have: effect for reducing blood fat also has the growth of tangible cholesterol reducing effect, the protective effect to liver, diuresis, inhibition tubercule bacillus.
Cortex Moutan: hardship, suffering is slightly cold, GUIXIN, liver, kidney channel.Effect: clearing away heat and cooling blood, promoting blood circulation to remove blood stasis.Cure mainly the epidemic febrile disease pathogenic heat attacking blood system in febrile diseases; Send out speckle; Tell nosebleed; Brimful of tears.The pathogenic bacteria later stage, hot Fu Yin divided heating; Deficiency of YIN osteopyrexia and fever; Amenorrhea due to stagnation of blood; Dysmenorrhea; Carbuncle sore tumefacting virus; Fall and pounce on the pain of injury; The rheumatism pyretic arthralgia.Chemical constituent: paeonol.Modern pharmacological research: but the Cortex Moutan coronary blood flow increasing reduces cardiac output, and protection heart, antiinflammatory action, bacteriostasis, anticoagulation etc. are arranged.
The Rhizoma Atractylodis Macrocephalae: bitter in the mouth, sweet, temperature.Return spleen, stomach warp.Function cures mainly: invigorating the spleen and benefiting QI, and the dampness diuretic, hidroschesis, antiabortive.Be used for insufficiency of the spleen lack of appetite, abdominal distention is had loose bowels, phlegm retention vertigo and palpitation, edema, exterior deficiency spontaneous perspiration, frequent fetal movement.Be used for weakness of the spleen and stomach again, the lack of appetite distension, fatigue and weakness is had loose bowels.The pharmacological action relevant with Rhizoma Atractylodis Macrocephalae invigorating the spleen and benefiting QI effect is for adjusting gastrointestinal motility function, antiulcer, protect the liver, enhancing human body immunity function, anti-stress, making effects such as strengthening the blood function; Its dampness diuretic effect is relevant with diuresis; And antiabortive effect is relevant with the effect of inhibition uterine contraction.The Rhizoma Atractylodis Macrocephalae also has effects such as antioxidation, slow down aging, blood sugar lowering, anticoagulation, antitumor.
Rhizoma sparganic: acrid in the mouth, hardship, flat.Return liver, spleen channel.Function cures mainly, removing blood stasis circulation of qi promoting, removing food stagnancy pain relieving.Be used for the lump in the abdomen mass in the abdomen, blood stasis amenorrhea, food stagnation distending pain.Cure mainly: the lump in the abdomen mass in the abdomen; The stasis of blood amenorrhea that stagnates; Dysmenorrhea; The food stagnation distending pain; Fall and pounce on the pain of injury
Chemical constituent: contain volatile oil, main component is phenethanol, hydroquinone, hexadecylic acid in the oil, removes stem constuslactone etc. and multiple organic acid, pharmacological action: water extract can the significant prolongation thrombin to the pool time of human fibrin; Water decoction is anticoagulant significantly, reduces whole blood viscosity; Can obviously prolong thrombin time of blood plasma; The outer thrombosis of energy antibody, and make the thrombosis time lengthening, the thrombosis contraction in length, thrombus weight alleviates, and the euglobulin time is shortened.
Fructus Crataegi: sour in the mouth, sweet, tepor is returned spleen, stomach, Liver Channel, and effect cures mainly: promoting digestion and removing stagnation, promoting blood circulation to remove blood stasis is used for meat stagnation, stomach alkane distension, dysentery stomachache, blood stasis amenorrhea, postpartum stagnation, trusted subordinate's twinge, hernia pain, hyperlipidemia.Main component: tartaric acid, citric acid, flavonoid, glycoside lactone, saccharide, gentle matter.Discover that Fructus Crataegi can give protection against cancer, anticancer, heart tonifying, blood fat reducing, blood pressure lowering, treatment dysmenorrhea, menoxenia.
Hirudo: salty, hardship, flat, slightly poisonous.Return Liver Channel, effect cures mainly: removing blood stasis, removing blood stasis stimulates the menstrual flow.Control blood-retention ， mass in the abdomen, gather, women's amenorrhea, blood stasis becomes consumptive disease, injury from falling down, conjunctival congestion with ophthalmalgia, nebula.Modern pharmacological research: its tool anticoagulant effect, thrombolytic effect, effect for reducing blood fat, termination of pregnancy effect.
Rhizoma Chuanxiong: suffering, temperature.Return liver, gallbladder, pericardium channel.Blood-activating and qi-promoting, wind-expelling pain-stopping.Be used for menoxenia, amenorrhea dysmenorrhea ， mass in the abdomen stomachache, the twinge of the breast side of body, tumbling and swelling, headache, rheumatic arthralgia.Chemical constituent: contain volatile oil, ferulic acid, and 4-hydroxyl-thick lactone of 3-butyl, senkyunolide, ligustilide, ligustrazine, chuanxingol, sedanoic acid etc.
Rhizoma Cyperi: the little hardship of acrid in the mouth is sweet, and property is flat.Go into liver, tri-jiao channel.Function cures mainly: the resolving depression of regulating the flow of vital energy, menstruction regulating and pain relieving.Be used for stagnation of QI due to depression of the liver, breast, the side of body, abdominal distention, dyspepsia, menoxenia, amenorrhea dysmenorrhea, colic of cold type stomachache, distending pain of the breast.Chemical analysis: rhizome contains volatile oil, and root contains the material that suppresses some fungi development.This medicine is fried black then hemostasis, and the salt water logging is fried and then gone into blood system and moisturize, and Halitum is fried then the kidney invigorating gas, and steeping in wine is fried the network of then passing through, and vinegar soaks fries that then removing food stagnancy is poly-, and Sucus Zingberis is fried the drink that then reduces phlegm.Must join, art QI invigorating then, must return, then enrich blood, the Radix Aucklandiae then flow stagnate and in, Lignum Santali Albi is then regulated the flow of vital energy and is amusing, get the then all gas of lifting of Lignum Aquilariae Resinatum, Rhizoma Chuanxiong, Rhizoma Atractylodis are then dissolved Zhu Yu, Fructus Gardeniae, Rhizoma Coptidis then can pathogenic fire reducing heat, Poria cum Radix Pini then hand over Ji heart kidney, Fructus Foeniculi, Fructus Psoraleae then bleed return unit, Cortex Magnoliae Officinalis, the Rhizoma Pinelliae are then certainly stopped up relieving distension, Folium Perillae, the very light blue gloom-dispelling of then separating, rhizoma sparganic,
Rhizoma CurcumaeThen wear down long-pending piece, get Folium Artemisiae Argyi and then control vim and vigour, warm uterus.Be the Directorate-General DG of disorder of QI, the chief commander of women section also.
Chinese medicine is thought and is caused gynecological's lower abdomen pain, profuse leukorrhea, lumbosacral aching pain, pelvic adhesion, hysteromyoma, ovarian cyst, menoxenia, dysmenorrhea, disease such as infertile reason manyly cause qi depression to blood stasis by liver,spleen,kidney three dirty functional disorders, above all diseases appear in stagnation of phlegm-damp, its common pathogenesis is arranged, make its three dirty function be in harmonious proportion then all diseases from disappearing by secular Drug therapy.This has demonstrated fully the rule of traditional Chinese medical science treating different diseases with the same therapeutic principle.
Compared with the prior art, beneficial effect of the present invention is embodied in:
1, medication of the present invention is reasonable, the compatibility science.In the compatibility of the present invention, decoction for the treatment principle: replenishing QI to invigorate the spleen dampness removing, blood circulation promoting and blood stasis dispelling Xiao Disorder.Radix Angelicae Sinensis, Radix Paeoniae Rubra, Rhizoma Chuanxiong are that SIWU TANG is removed Radix Rehmanniae Preparata in the side, and nourishing and enriching blood is invigorated blood circulation, to control dysmenorrhea, menoxenia; The Ramulus Cinnamomi activating YANG and prormoting functioning of QI, warm promoting blood circulation; The heat-transformation of a specified duration of the stasis of blood piece stasis of blood, so with Radix Paeoniae Rubra, Semen Persicae, Cortex Moutan blood stasis dispelling blood, clear stagnant heat.Poria, Rhizoma Atractylodis Macrocephalae invigorating spleen to remove dampness, Rhizoma Alismatis is sweet light, promoting diuresis to eliminate damp pathogen, heat of letting out kidney and bladder cold in nature, the damp-heat in lower-JIAO person is particularly suitable, to control pelvic inflammatory disease, fallopian tube adhesion, infertile, profuse leukorrhea, stomachache, ovarian cyst etc., the Fructus Crataegi promoting blood circulation, removing blood stasis and relieving pain, particularly suitable to dysmenorrhea, menoxenia; The Radix Salviae Miltiorrhizae merit is with four things simply, and the nourishing blood to tranquillize the mind effect is arranged; Hirudo, removing blood stasis (removing blood stasis with potent drugs blood and do not hinder fresh blood), removing blood stasis stimulates the menstrual flow, and controls blood-retention ， mass in the abdomen, gathers, and women's amenorrhea, blood stasis become consumptive disease; Rhizoma sparganic, removing blood stasis circulation of qi promoting, removing food stagnancy pain relieving.Be used for the lump in the abdomen mass in the abdomen, the blood stasis amenorrhea; Rhizoma Cyperi goes into liver, tri-jiao channel, the resolving depression of regulating the flow of vital energy, menstruction regulating and pain relieving.Cure mainly menoxenia, the amenorrhea dysmenorrhea, colic of cold type stomachache, distending pain of the breast is joined then QI invigorating of the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, gets Radix Angelicae Sinensis and then enriches blood, and join rhizoma sparganic, Rhizoma Curcumae and then wear down long-pending piece, be the Directorate-General DG of disorder of QI, the principal agent of women section is walked circulation of qi promoting of blood system with Rhizoma Chuanxiong compatibility one; Prolonged illness is felt frustrated again, also feels frustrated with the sharpening medicine of invigorating blood circulation for a long time, so the compatibility Radix Astragali can beneficial vigour and mended three warmers, the skin infection of expelling the toxic substance from the body with tonic YIN syndrome, the spontaneous perspiration of consolidating superficial resistance void.Modern pharmacological research: Hirudo has thrombolytic, effect for reducing fat; Rhizoma sparganic reduces the outer thrombosis of whole blood viscosity energy antibody; Rhizoma Atractylodis Macrocephalae antiulcer, protect the liver, enhancing human body immunity power, strengthen hemopoietic function; Cortex Moutan has antiinflammatory, antibacterial, anticoagulation; Semen Persicae blood stasis dispelling blood, antiinflammatory, antiallergic.Pharmaceutical analysis to sum up, full side's compatibility is rigorous, and medication is reasonable, suits pathogenesis, and dialectical medication combines with modern pharmacological research, cures the disease and does not stay heresy, gets rid of evils and does not just hinder, and treating both the principal and secondary aspects of a disease does not stay future trouble.All medicines share plays the spleen invigorating of invigorating blood circulation altogether, the usefulness of dampness removing Xiao Disorder.
2, the present invention routine patient surplus the clinical treatment 300, effective percentage reaches 100%, and cure rate reaches 90%.
3, technology of the present invention is simple, and treatment is convenient, and instant effect has no side effect, and does not recur after healing, and expense cost is low.
Consumption of the present invention is: oral each 3 (containing crude drug 1.5g altogether), three times on the one, taking medicine after meal, boiled water takes.
The specific embodiment
In concrete the enforcement, treatment gynecological lower abdomen pain, profuse leukorrhea, lumbosacral aching pain, pelvic adhesion, hysteromyoma, ovarian cyst, menoxenia, dysmenorrhea, the Chinese medicine of disease such as infertile can be filled a prescription by following tabulation,
Subordinate list:
Present embodiment carries out compatibility of drugs by the 2nd group of value in the table:
Radix Angelicae Sinensis 10g Radix Paeoniae Alba 10g Rhizoma Chuanxiong 10g Ramulus Cinnamomi 10g Radix Salviae Miltiorrhizae 15g Radix Astragali 15g Radix Paeoniae Rubra 10g Poria 15g Cortex Moutan 10g Semen Persicae 10g Rhizoma Atractylodis Macrocephalae 12g Rhizoma Alismatis 10g rhizoma sparganic 8g Fructus Crataegi 15g Hirudo 3g Rhizoma Cyperi 10g
In table in 5 groups of compatibility of drugs values: 1 group of compatibility of drugs dosage is lighter, does not probably reach disease institute; 3 groups activating blood and removing stasis drug dosage is heavier and Qi-tonifying drug is slightly inadequate; Invigorating spleen to remove dampness medicine, drug for invigorating blood circulation and eliminating stasis and warming YANG activating QI medicine ratio discomfort are either large or small in 4 groups and 5 groups; The 2nd group, drug dose and compatibility suit pathogenesis, meet the replenishing QI to invigorate the spleen dampness removing, the Therapeutic Principle of blood circulation promoting and blood stasis dispelling Xiao Disorder.So we select the 2nd group.
The preparation process of medicine is:
1, all medicinal pulverizers are pulverized, and break into 80 order medicated powder.
2, medicated powder is adopted Chinese patent medicine vacuum drying sterilization cabinet sterilizing installation sterilize;
3, the medicated powder of sterilizing, make every zero capsule that contains 0.5g medicated powder, in the bottle of packing into, hermetic container is preserved the standby finished product that is.
Model case
1 fallopian tube adhesion umbrella end hydrops is infertile
Poplar, 28 years old, first visit on February 4th, 2008.Private prosecution in April, 2007 because of pregnant 45 days ectopic pregnancy in row right side, outer court salpingectomy, now prepare again conceivedly, and the recent months unpregnancy of not practising contraception comes to go to a doctor.Now after clean 3 days.Question closely medical history: the patient is the eumenorrhea at ordinary times, once about two months in the ectopic pregnancy postoperative, because of lower abdominal pain companion hyperpyrexia once, behind venous transfusion, antiinflammatory symptomatic treatment and fully recover.Childbearing history: 1-0-3-1.Gynecologial examination: vagina is smooth, and secretions is normal, waste in the cervix uteri, anteversion of uterus, movable general, light tenderness, the right side fallopian tube lack as, the left side increases slightly and thickens.The descending hysterosalpingography of routine disinfection, result: left side fallopian tube adhesion.Existing patient's ordinary circumstance is good, and pain is weighed down in the lower abdomen left side sometimes.See angry of its Sublingual venation, stringy and rolling pulse.It is oral promptly to give the scorching capsule for eliminating of the Disorder of woman section, one day three times, one time three, serve on 20 days, do not have sense of discomfort after the medication, left lower quadrant weighs down pain and disappears, and the Sublingual venation is alleviated slightly, inform one course of treatment of the oral at once treatment by Chinese herbs of the present invention of clean back 3 days of every menstruation, 20 days, continuous 6 months.Occur menolipsis with to the 5th course of treatment time, surveyed the urine HCG positive, ultrasound diagnosis in 50 days in 40 days: early pregnancy in utero.Back term labor one boy baby.
2 hysteromyoma
Zhao, 40 years old, outpatient service was gone to a doctor number on February 7th, 09638,2007.Hysteromyoma 10 days are found in health check-up.Patient G3P1, in April, 2000 because of menostaxis not to the utmost 50 days B ultrasonic show: subserous myoma of uterus, the size about 6CM * 7CM, give the hysteromyoma evidement.All recover normal postoperative, and in pregnant 49 days of in April, 2005 pedestrian's stream once, postoperative is no abnormal.Unit health check-up before 10 days, B ultrasonic has been found hysteromyoma again, does not now have any symptom, but the gloomy utmost point that causes of heart, can consulting expectant treatment.Gynecologial examination: vaginal secretions is normal, and cervix uteri is smooth, and the anteversion of uterus mobility is general, and adhesion is arranged slightly, increases as pregnant 50 days, and matter is hard, owes rule, light tenderness, and the bilateral adnexa does not touch obviously unusual.B ultrasonic check prompting: anterior uterine wall Subserous myoma, 1.6CM * 2CM.See its purplish tongue, white and thin fur, stringy and hesitant pulse is intended blood circulation promoting and blood stasis dispelling, pain relieving Xiao Disorder.Give extract oral of the present invention, one day three times, one time three, serve on 20 days, begin a weekly dose and double, the back of taking medicine does not have uncomfortable, informs that each menstruation promptly took medicine 15-20 days after clean, it is surplus so to take June, the row ultrasound diagnosis, uterus adnexa shows no obvious abnormalities.Followed up a case by regular visits to, and do not see recurrence in 1 year.
3 dysmenorrheas
Jiang, 30 years old, outpatient service number 003592, May 20 2006 first visit time.Dysmenorrhea is more than 5 years, and the dysmenorrhea degree was lighter in the past, from the second half of last year dysmenorrhea increase the weight of cold and pain in the lower abdomen during outbreak gradually, sometimes can not bear certainly, temperature is applied to push slightly and is alleviated, and menstrual cycle is normal substantially, purple coloured menses, less through measuring, clot is more, and leukorrhagia is no abnormal, and diet two just can.Last menstrual period was risen childbearing history May 1: 2-0-2-2, and bilateral tubal ligation 1 year, light red tongue tongue the lung-pulse is thin.Gynecologial examination: pudendum is not different from, and vagina is smooth, and cervix uteri is smooth, position behind the body of palace, and normal size, movable, quality is medium, no tenderness, the both sides adnexa does not have tenderness, and three close and examine the coarse tenderness of right side jarjavay's ligaments.Western medicine diagnose is: endometriosis.Control with blood circulation promoting and blood stasis dispelling dispersing cold for relieving pain.Give extract oral of the present invention, one day three times, one time three, serve on 20 days menstrual onsets, pain relief can be born certainly, and is bright slightly through color, clot reduces, 5 days clean.Advise menstruation in its every month to take medicine in preceding 15 days, so continuous 6 months, dysmenorrhea was more followed up a case by regular visits to painless through taking place after 1 year.
Claims (2)
1. Chinese medicinal capsule for the treatment of gynaecopathia, it is characterized in that: the weight proportion of its raw material components is:
Radix Angelicae Sinensis 10-15g Radix Paeoniae Alba 10-12g Rhizoma Chuanxiong 9-10g Ramulus Cinnamomi 10-12g Radix Salviae Miltiorrhizae 15-20g Radix Astragali 12-20g Radix Paeoniae Rubra 10-12g Poria 10-15g Cortex Moutan 10-12g Semen Persicae 10-12g Rhizoma Atractylodis Macrocephalae 10-15g Rhizoma Alismatis 10-12g rhizoma sparganic 5-10g Fructus Crataegi 10-15g Hirudo 2-5g Rhizoma Cyperi 10-12g.
2. the Chinese medicinal capsule of treatment gynaecopathia according to claim 1 is characterized in that: the weight proportion of its raw material components is:
Radix Angelicae Sinensis 10g Radix Paeoniae Alba 10g Rhizoma Chuanxiong 10g Ramulus Cinnamomi 10g Radix Salviae Miltiorrhizae 15g Radix Astragali 15g Radix Paeoniae Rubra 10g Poria 15g Cortex Moutan 10g Semen Persicae 10g Rhizoma Atractylodis Macrocephalae 12g Rhizoma Alismatis 10g rhizoma sparganic 8g Fructus Crataegi 15g Hirudo 3g Rhizoma Cyperi 10g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010505055XA CN102068641B (en) | 2010-10-09 | 2010-10-09 | Chinese medicinal capsules for treating gynecological diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010505055XA CN102068641B (en) | 2010-10-09 | 2010-10-09 | Chinese medicinal capsules for treating gynecological diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102068641A true CN102068641A (en) | 2011-05-25 |
| CN102068641B CN102068641B (en) | 2012-06-13 |
Family
ID=44027521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201010505055XA Expired - Fee Related CN102068641B (en) | 2010-10-09 | 2010-10-09 | Chinese medicinal capsules for treating gynecological diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102068641B (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102247581A (en) * | 2011-08-18 | 2011-11-23 | 王思曾 | Medicament for treating myoma of uterus |
| CN103211995A (en) * | 2013-04-28 | 2013-07-24 | 长治市郊区黄碾镇中心卫生院 | Medicament for treating ovarian cyst |
| CN103356969A (en) * | 2013-07-26 | 2013-10-23 | 黄淑娟 | Traditional Chinese medicine composition for treating hysteromyoma |
| CN103638297A (en) * | 2013-11-19 | 2014-03-19 | 靖江市明星水蛭养殖专业合作社 | Traditional Chinese medicine preparation used for improving female menoxenia, and preparation method thereof |
| CN103784767A (en) * | 2014-02-20 | 2014-05-14 | 柳晖 | Traditional Chinese medicine composition for treating preceded menstural cycle |
| CN104997926A (en) * | 2015-08-19 | 2015-10-28 | 宫锡和 | Preparation method of traditional Chinese medicine preparation for treating gynaecology and internal haemorrhage |
| CN104998183A (en) * | 2015-08-06 | 2015-10-28 | 苏州神林堂中医药研究所 | Traditional Chinese medicine combination for treating dysmenorrhea |
| CN105079543A (en) * | 2015-08-24 | 2015-11-25 | 南京正宽医药科技有限公司 | Medicinal preparation for treating ovarian cyst |
| CN105361994A (en) * | 2015-10-23 | 2016-03-02 | 河北工程大学 | Portable dysmenorrhea treatment instrument capable of massaging and generating heat |
| CN106138924A (en) * | 2016-08-08 | 2016-11-23 | 广西罗塞塔生物工程有限公司 | A kind of Chinese medicine preparation treating dysmenorrhea and preparation method thereof |
| CN106390021A (en) * | 2016-10-19 | 2017-02-15 | 北京朝阳中西医结合急诊抢救中心 | Pharmaceutical composition for preventing and treating uterine fibroid and ovarian cyst as well as preparation method, dosage form and application of pharmaceutical composition |
| CN117815296A (en) * | 2024-01-30 | 2024-04-05 | 中国中医科学院广安门医院 | A Chinese medicine composition for treating gynecological diseases and its preparation method and use |
-
2010
- 2010-10-09 CN CN201010505055XA patent/CN102068641B/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 《辽宁中医药大学学报》 20070930 林倩雯等 子宫肌瘤的中医治疗概况 62-63 1-2 第9卷, 第5期 2 * |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102247581B (en) * | 2011-08-18 | 2013-03-27 | 王思曾 | Medicament for treating myoma of uterus |
| CN102247581A (en) * | 2011-08-18 | 2011-11-23 | 王思曾 | Medicament for treating myoma of uterus |
| CN103211995A (en) * | 2013-04-28 | 2013-07-24 | 长治市郊区黄碾镇中心卫生院 | Medicament for treating ovarian cyst |
| CN103356969A (en) * | 2013-07-26 | 2013-10-23 | 黄淑娟 | Traditional Chinese medicine composition for treating hysteromyoma |
| CN103638297A (en) * | 2013-11-19 | 2014-03-19 | 靖江市明星水蛭养殖专业合作社 | Traditional Chinese medicine preparation used for improving female menoxenia, and preparation method thereof |
| CN103784767A (en) * | 2014-02-20 | 2014-05-14 | 柳晖 | Traditional Chinese medicine composition for treating preceded menstural cycle |
| CN104998183A (en) * | 2015-08-06 | 2015-10-28 | 苏州神林堂中医药研究所 | Traditional Chinese medicine combination for treating dysmenorrhea |
| CN104997926A (en) * | 2015-08-19 | 2015-10-28 | 宫锡和 | Preparation method of traditional Chinese medicine preparation for treating gynaecology and internal haemorrhage |
| CN105079543A (en) * | 2015-08-24 | 2015-11-25 | 南京正宽医药科技有限公司 | Medicinal preparation for treating ovarian cyst |
| CN105361994A (en) * | 2015-10-23 | 2016-03-02 | 河北工程大学 | Portable dysmenorrhea treatment instrument capable of massaging and generating heat |
| CN106138924A (en) * | 2016-08-08 | 2016-11-23 | 广西罗塞塔生物工程有限公司 | A kind of Chinese medicine preparation treating dysmenorrhea and preparation method thereof |
| CN106390021A (en) * | 2016-10-19 | 2017-02-15 | 北京朝阳中西医结合急诊抢救中心 | Pharmaceutical composition for preventing and treating uterine fibroid and ovarian cyst as well as preparation method, dosage form and application of pharmaceutical composition |
| CN117815296A (en) * | 2024-01-30 | 2024-04-05 | 中国中医科学院广安门医院 | A Chinese medicine composition for treating gynecological diseases and its preparation method and use |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102068641B (en) | 2012-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102068641B (en) | Chinese medicinal capsules for treating gynecological diseases | |
| CN105477616A (en) | Medicine for easing mental anxiety, reducing phlegm, restoring consciousness and promoting blood circulation to remove meridian obstruction and preparation method thereof | |
| CN104208554A (en) | Traditional Chinese medicine mainly for treating multiple female diseases | |
| CN104758852A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN102058870B (en) | Medicine for treating rheumatic and rheumatoid arthralgia, stroke and hemiplegia and preparation method thereof | |
| CN102836409A (en) | Traditional Chinese medicine for treating postpartum lochiorrhea and preparation method | |
| CN102488875B (en) | Traditional Chinese medicine for treating acquired dysmenorrhea | |
| CN104800634A (en) | Medicine for treating hypertension and preparation method thereof | |
| CN104043022A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN104524335A (en) | Pill for conditioning female endocrine disorders and preparation method of pill | |
| CN104740437A (en) | Traditional Chinese medicine composition for treating constipation and preparation method of traditional Chinese medicine composition | |
| CN104740268A (en) | Traditional Chinese medicinal composition for treating coronary heart disease | |
| CN101966260B (en) | Chinese medicinal capsules for treating limb numbness and pain of diabetic concurrent peripheral neuropathy | |
| CN104189278A (en) | Traditional Chinese medicine preparation for treating menstrual disorder and preparation method thereof | |
| CN102274445A (en) | Cassia twig common burreed rhizome tumor eliminating pills | |
| CN104906507A (en) | Traditional Chinese medicine combination for lowering blood pressure and toning physical fitness | |
| CN101485867A (en) | Chinese medicinal composition for treating varix and preparation method thereof | |
| CN105232987A (en) | Traditional Chinese medicine promoting neurosurgery postoperative rehabilitation | |
| CN104721758A (en) | Pharmaceutical for treating ovarian cyst and preparing method thereof | |
| CN104398927A (en) | Traditional Chinese medicinal preparation for treating gonarthromeningitis | |
| CN105435131A (en) | Traditional Chinese medicine composition for treating chronic heart failure and preparation method thereof | |
| CN105267538A (en) | Pilose antler paste for treatment of irregular menstruation and preparation method thereof | |
| CN103356959B (en) | Pharmaceutical composition for treating hyperplasia of mammary glands | |
| CN105688075A (en) | Novel oral preparation for treating stomachache and preparation method thereof | |
| CN104800723A (en) | Traditional Chinese medicine formula for treating blood stasis type irregular menstruation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120613 Termination date: 20151009 |
|
| EXPY | Termination of patent right or utility model |